Меню
Набор скоро начнётся NCT06957522

Comparison of the Effectiveness of Face to Face Rehabilitation and Telerehabilitation in Infants With Congenital Muscular Torticollis

Без фазы С лечением Infant Torticollis Congenital Neurodevelopment Treatment Telerehabilitation

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: face to face rehabilitation, telerehabilitation.
Кому может быть актуально
Состояния в реестре: Infant, Torticollis Congenital, Neurodevelopment Treatment, Telerehabilitation. Базовые параметры: 0 мес. — 6 мес. · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Turkey (Türkiye)
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

Who is this study for? This study is designed for infants aged 0-6 months who have been diagnosed with Congenital Muscular Torticollis (CMT). CMT is a condition observed at birth or shortly after, characterized by the shortening of the sternocleidomastoid (SCM) muscle, leading to the baby's head tilting to one side and rotating to the opposite side. It affects both boys and girls and may result in limited neck movement, abnormal posture, facial asymmetry, and potential developmental delays if left untreated. What is the purpose of this study? The goal of this study is to compare the effectiveness of two different physical therapy methods-face-to-face rehabilitation and telerehabilitation-in treating infants with CMT. In addition to evaluating the outcomes of these two therapy methods, this research also aims to provide families with reliable, accessible information through a web-based educational platform. Why is this study important? Early diagnosis and intervention are crucial for optimal recovery in infants with CMT. Studies show that infants who begin therapy by one month of age have up to a 98% chance of full recovery. However, if diagnosis and treatment are delayed, the recovery process can take longer and may be less effective. This study will help determine if online (telerehabilitation) sessions can be just as effective as traditional face-to-face therapy, offering a flexible and accessible treatment option for families. What are the benefits of participating? * Access to a structured, evidence-based rehabilitation program for your child * Guidance from trained pediatric physiotherapists * Increased awareness and knowledge about CMT through a web-based family education platform * Contribution to research that may benefit other children and families in the future * Evaluation of your baby's progress through professional assessments What will the therapy program involve? Participants will be randomly assigned to either a face-to-face or telerehabilitation group. Both groups will follow the same therapy program, focusing on: * Increasing passive and active neck movements * Promoting symmetrical head and body movement * Providing recommendations for environmental adjustments * Educating parents or caregivers on home-based exercises and care Program structure: * Face-to-face group: Therapy sessions will be conducted in a clinic setting, twice a week for 30 minutes each session, over a period of 8 weeks. * Telerehabilitation group: Therapy sessions will be conducted via Zoom, with the same frequency, duration, and content as the face-to-face sessions. How will outcomes be measured? Infants will be assessed before and after the 8-week therapy period for: * Passive cervical range of motion (rotation and lateral flexion) * Gross motor function * Muscle function Parental adherence to the home program will also be evaluated through a questionnaire. A follow-up will be conducted one month after therapy ends. How can I participate? If your infant is aged 0-6 months and has been diagnosed with CMT, you may be eligible to participate. You will need access to a device with internet for telerehabilitation sessions, if assigned to that group. Participation is voluntary and free of charge. Families will receive detailed instructions and ongoing support throughout the program. Additional Resources: As part of this study, a web-based educational platform will be made available to all participating families. This platform will include: * Clear explanations about CMT * Instructional videos and home exercise guides * Tips for daily care and positioning * Frequently asked questions (FAQ) for parents Why is this research unique? This is one of the first studies to scientifically compare face-to-face and online rehabilitation for CMT infants, while also providing a reliable online resource for families. It aims to help develop alternative, flexible care models that meet the diverse needs of families and infants. Contact Information: If you are interested in participating or would like more information, please contact our research team at: \[fgokcenalaca@gmail.com / +905534646606\] We are committed to supporting your child's health and development. Thank you for considering being a part of this important study.

Подробное описание

Study Design This study is designed as a prospective, randomized controlled clinical trial to compare the effectiveness of face-to-face and telerehabilitation programs in infants diagnosed with Congenital Muscular Torticollis (CMT) between 0-6 months of age. Both groups will receive an identical intervention protocol, consisting of two sessions per week, 30 minutes each, over a total of 8 weeks.

The intervention content includes exercises to increase active cervical range of motion (ROM), activities promoting symmetrical movements, family education, home exercise programs, and practices to support gross motor development.

Study Population and Sample Size In a study by Lee et al. (2015), the effect size for head tilt angle was calculated as 1.45. Based on this effect size, with α = 0.05 and a power of 99%, the required sample size was determined to be 19 participants per group. With an anticipated 15% drop-out rate, the total sample size was set at 42 infants.

Inclusion Criteria

* Diagnosed with Congenital Muscular Torticollis (CMT) * Infants under 6 months of age * Classified as level 1 to 3 according to the CMT classification system

Exclusion Criteria

* Presence of ocular torticollis * Neurological complications (e.g., cerebral palsy) * Congenital anomalies of the cervical spine or spinal cord * Visual or auditory impairments

Participant Recruitment and Randomization Infants referred with a diagnosis of CMT will be screened, and those who meet the inclusion criteria will be invited to participate. Families will be informed in detail, and written informed consent will be obtained. Participants will be randomly allocated into two groups (face-to-face and telerehabilitation) using computer-generated simple randomization (n = 21 per group).

Outcome Measures

All outcomes will be assessed at baseline and after the 8-week intervention period:

* Passive cervical range of motion (ROM): Measured using a goniometer * Alberta Infant Motor Scale (AIMS): To evaluate gross motor development * Head tilt angle: Assessed using a standardized photographic measurement protocol * Muscle Function Scale: To assess the functional status of neck muscles * Adherence to home exercise program: Evaluated through a parent-reported checklist

Statistical Analysis Data will be analyzed using SPSS version 26.0 (IBM Corp, Armonk, NY). Descriptive statistics (mean, standard deviation, frequency, percentage) will be presented for both categorical and continuous variables. The Levene test will be used to assess homogeneity of variances. For between-group comparisons, independent-samples t-test will be used for normally distributed data; otherwise, the Mann-Whitney U test will be applied. A p-value \< 0.05 will be considered statistically significant.

Research Hypotheses H₀: There is no significant difference between telerehabilitation and face-to-face rehabilitation in infants with CMT in terms of cervical ROM, gross motor function, muscle function, and parental adherence.

H₁: There is a significant difference between telerehabilitation and face-to-face rehabilitation in infants with CMT in terms of cervical ROM, gross motor function, muscle function, and parental adherence.

Вмешательства

  • Другое face to face rehabilitation
    The face-to-face rehabilitation program will be delivered in a clinical setting to infants aged 0-6 months with congenital muscular torticollis (CMT). It is based on neurodevelopmental treatment (NDT) principles and consists of: Passive range of motion (ROM) exercises for the neck Active ROM exercises for the neck and trunk Activities to promote the development of symmetrical movement Environmental modification suggestions for the home setting Parent/caregiver education and training Sessio
  • Другое telerehabilitation
    The telerehabilitation program provides the same therapeutic content as the face-to-face rehabilitation group but will be delivered remotely via the Zoom video conferencing platform. The program will be applied to infants aged 0-6 months with congenital muscular torticollis (CMT) and is based on neurodevelopmental treatment (NDT) principles, including: Passive range of motion (ROM) exercises for the neck Active ROM exercises for the neck and trunk Activities for symmetrical movement developme

Первичные конечные точки

  • Passive Cervical Range of Motion (Lateral Flexion and Rotation) [Срок оценки: Baseline, Week 8 (post-treatment), and 1-month follow-up]
  • Head Tilt Angle (Still Photography Method) [Срок оценки: Baseline, Week 8 (post-treatment), and 1-month follow-up]
Вторичные конечные точки (2)
  • Muscle Function Test (MFT) [Срок оценки: Baseline, Week 8 (post-treatment), and 1-month follow-up]
  • Alberta Infant Motor Scale (AIMS) [Срок оценки: Baseline, Week 8 (post-treatment), and 1-month follow-up]

Критерии участия

Критерии включения

  • Infants aged 0 to 6 months
  • Diagnosed with congenital muscular torticollis (CMT)
  • Classified as Grade 1 to 3 CMT severity based on clinical assessment

Критерии исключения

  • Plagiocephaly
  • Ocular torticollis
  • Neurological complications
  • Musculoskeletal disorders of the cervical spine
  • Visual impairments
  • Hearing impairments

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Лечение

Центры проведения

Turkey (Türkiye) · 1 центр
  • Istanbul University - Cerrahpasa, Faculty of Health Sciences, Büyükçekmece Campus, Alkent — Istanbul

Публикации

  • Rodriguez-Huguet M, Rodriguez-Almagro D, Rosety-Rodriguez MA, Vinolo-Gil MJ, Ayala-Martinez C, Gongora-Rodriguez J. Effectiveness of the Treatment of Physiotherapy in the Congenital Muscular Torticollis: A Systematic Review. Children (Basel). 2023 Dec 20;11(1):8. doi: 10.3390/children11010008. PMID 38275429
  • Sargent B, Coulter C, Cannoy J, Kaplan SL. Physical Therapy Management of Congenital Muscular Torticollis: A 2024 Evidence-Based Clinical Practice Guideline From the American Physical Therapy Association Academy of Pediatric Physical Therapy. Pediatr Phys Ther. 2024 Oct 1;36(4):370-421. doi: 10.1097/PEP.0000000000001114. Epub 2024 Oct 1. PMID 39356257
  • Castilla A, Gonzalez M, Kysh L, Sargent B. Informing the Physical Therapy Management of Congenital Muscular Torticollis Clinical Practice Guideline: A Systematic Review. Pediatr Phys Ther. 2023 Apr 1;35(2):190-200. doi: 10.1097/PEP.0000000000000993. Epub 2023 Jan 10. PMID 36637442
  • Kaplan SL, Coulter C, Sargent B. Physical Therapy Management of Congenital Muscular Torticollis: A 2018 Evidence-Based Clinical Practice Guideline From the APTA Academy of Pediatric Physical Therapy. Pediatr Phys Ther. 2018 Oct;30(4):240-290. doi: 10.1097/PEP.0000000000000544. PMID 30277962

Идентификаторы

NCT: NCT06957522 · GErol1

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗